Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Free PDFs: Hepatology 2013 (574 pages) – Hepatitis C 2013 Amedeo Smart: the Smartphone Edition	Free Abstracts

Hepatitis

Free Subscription 25.03.2013 1 Am J Gastroenterol 1 BMC Gastroenterol 1 Clin Infect Dis 2 Dig Dis Sci 2 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 7 Hepatology 1 Int J STD AIDS 3 J Hepatol 5 J Med Virol 27 J Viral Hepat 1 J Virol 2 Lancet 1 PLoS Comput Biol 6 PLoS One 1 Proc Natl Acad Sci U S A 3 Transplant Proc 1 Transplantation 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. SEARS DM , Cohen DC, Ackerman K, Ma JE, et al
   Birth Cohort Screening for Chronic Hepatitis During Colonoscopy Appointments.
   Am J Gastroenterol. 2013 Mar 19. doi: 10.1038/ajg.2013.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   BMC Gastroenterol

2. STINTON LM , Myers RP, Coffin CS, Fritzler MJ, et al
   Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.
   BMC Gastroenterol. 2013;13:50.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Clin Infect Dis

3. MARKS M , Kulasegaram R
   Drug drug interactions and drug resistance will limit access to treatment in patients with HIV and Hepatitis C Co-Infection.
   Clin Infect Dis. 2013.
   PubMed     Text format     Related articles   
   
   
   

   
   Dig Dis Sci

4. MADDUKURI VC , Russo MW, Ahrens WA, Emerson SU, et al
   Chronic Hepatitis E with Neurologic Manifestations and Rapid Progression of Liver Fibrosis in a Liver Transplant Recipient.
   Dig Dis Sci. 2013.
   PubMed     Text format     Related articles   
   
   
   
5. MORENO-OTERO R
   May Oxidative Stress Contribute to Autoimmune Hepatitis Pathogenesis, and Can Antioxidants Be of Value as Adjuvant Therapy for Refractory Patients?
   Dig Dis Sci. 2013.
   PubMed     Text format     Related articles   
   
   
   

   
   Eur J Gastroenterol Hepatol

6. HYDES T , Allen H, Al-Shamma S, Hovell C, et al
   District general hospital networks can provide safe and effective hepatitis C treatment: results of a 5-year audit.
   Eur J Gastroenterol Hepatol. 2013.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. UCAR F , Sezer S, Ginis Z, Ozturk G, et al
   APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
   Eur J Gastroenterol Hepatol. 2013.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Gastroenterol Hepatol

8. KOUTSOUDAKIS G , Forns X, Perez-Del-Pulgar S
   [The molecular biology of hepatitis C virus.]
   Gastroenterol Hepatol. 2013 Mar 8. pii: S0210-5705(13)00014.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Hepatology

9. RODRIGUEZ C , Chevaliez S, Bensadoun P, Pawlotsky JM, et al
   Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing.
   Hepatology. 2013 Mar 15. doi: 10.1002/hep.26383.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. SUN JH , Gao M, Roberts S, Fridell R, et al
    Reply to correspondence: Low rates of naturally occuring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null responders.
    Hepatology. 2013 Mar 15. doi: 10.1002/hep.26381.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. TYSON GL , Kramer JR, Duan Z, Davila JA, et al
    Prevalence and predictors of hepatitis B virus co-infection in a united states cohort of hepatitis C virus-infected patients.
    Hepatology. 2013 Mar 16. doi: 10.1002/hep.26400.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MCPHEE F , Hernandez D, Yu F, Ueland J, et al
    Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir.
    Hepatology. 2013 Mar 15. doi: 10.1002/hep.26388.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. LARNEY S , Kopinski H, Beckwith CG, Zaller ND, et al
    The incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis.
    Hepatology. 2013 Mar 15. doi: 10.1002/hep.26387.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. SULKOWSKI MS , Bourliere M, Bronowicki JP, Asselah T, et al
    Faldaprevir combined with peginterferon Alfa-2a and ribavirin in chronic HCV genotype-1 patients with prior nonresponse: SILEN-C2 trial.
    Hepatology. 2013 Mar 15. doi: 10.1002/hep.26386.
    PubMed     Text format     Related articles   
    
    
    
15. LEE MH , Yang HI, Liu J, Batrla-Utermann R, et al
    Prediction models of long-term cirrhosis and HCC risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles.
    Hepatology. 2013 Mar 15. doi: 10.1002/hep.26385.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Int J STD AIDS

16. WEBSTER DP , Wojcikiewicz T, Keller M, Castelnovo D, et al
    Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and ribavirin.
    Int J STD AIDS. 2013.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Hepatol

17. KITSON MT , Button P, Roberts SK
    Reply to 'Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection'
    J Hepatol. 2013 Mar 11. pii: S0168-8278(13)00149.
    PubMed     Text format     Related articles   
    
    
    
18. WEINTRAUB SJ
    Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype I infection.
    J Hepatol. 2013 Mar 11. pii: S0168-8278(13)00150.
    PubMed     Text format     Related articles   
    
    
    
19. OLIVIERO B , Mele D, Degasperi E, Aghemo A, et al
    Natural Killer Cell Dynamic Profile Is Associated with Treatment Outcome in Patients with Chronic HCV Infection.
    J Hepatol. 2013 Mar 13. pii: S0168-8278(13)00152.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Med Virol

20. DESHMUKH TM , Shah RR, Gurav YK, Arankalle VA, et al
    Serum immunoglobulin G subclass responses in different phases of hepatitis E virus infection.
    J Med Virol. 2013;85:828-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. AVO AP , Agua-Doce I, Andrade A, Padua E, et al
    Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.
    J Med Virol. 2013;85:815-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. CHEONG JY , Shin HD, Kim YJ, Cho SW, et al
    Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection.
    J Med Virol. 2013;85:808-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. LI GJ , Hue S, Harrison TJ, Yang JY, et al
    Hepatitis B virus candidate subgenotype I1 varies in distribution throughout Guangxi, China and may have originated in Long An county, Guangxi.
    J Med Virol. 2013;85:799-807.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. ARATAKI K , Hayes CN, Akamatsu S, Akiyama R, et al
    Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B.
    J Med Virol. 2013;85:789-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Viral Hepat

25. CAMERON B , Galbraith S, Li H, Lloyd A, et al
    Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.
    J Viral Hepat. 2013;20:e96-e106.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. BORRONI G , Cazzaniga M, Andreoletti M, Ceriani R, et al
    Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C.
    J Viral Hepat. 2013;20:e90-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. LINDH M , Arnholm B, Bjorkman P, Hellstrand K, et al
    Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin.
    J Viral Hepat. 2013;20:e82-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. HOTHO DM , de Bruijne J, Spaan M, Treitel MA, et al
    Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up.
    J Viral Hepat. 2013;20:e78-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MAUSS S , Berger F, Schober A, Moog G, et al
    Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome.
    J Viral Hepat. 2013;20:e72-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. GOUKLANI H , Beyer C, Drummer H, Gowans EJ, et al
    Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production.
    J Viral Hepat. 2013;20:e66-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. ZHOU KN , Zhang M, Wu Q, Ji ZH, et al
    Reliability, validity and sensitivity of the Chinese (simple) Short Form 36 Health Survey version 2 (SF-36v2) in patients with chronic hepatitis B.
    J Viral Hepat. 2013;20:e47-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. WANG Y , Thongsawat S, Gane EJ, Liaw YF, et al
    Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B.
    J Viral Hepat. 2013;20:e37-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. SAKAMOTO T , Tanaka Y, Watanabe T, Iijima S, et al
    Mechanism of the dependence of hepatitis B virus genotype G on co-infection with other genotypes for viral replication.
    J Viral Hepat. 2013;20:e27-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. POPALIS C , Yeung LT, Ling SC, Ng V, et al
    Chronic hepatitis B virus (HBV) infection in children: 25 years' experience.
    J Viral Hepat. 2013;20:e20-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. NAIK A , Gupta N, Goel D, Ippagunta SK, et al
    Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area.
    J Viral Hepat. 2013;20:e138-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. NUNNARI G , Pinzone MR, Cacopardo B
    Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-up.
    J Viral Hepat. 2013;20:e131-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. W RIVERO C , Rosso N, Gentile E, Cuestas M, et al
    Dissimilar expression of multidrug resistance mdr1 and bcrp by the replication of hepatitis C virus: role of the nonstructural 5A protein.
    J Viral Hepat. 2013;20:e127-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. TAKAHASHI H , Mizuta T, Oeda S, Isoda H, et al
    An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C.
    J Viral Hepat. 2013;20:e124-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. FOSTER GR , Zeuzem S, Pianko S, Sarin SK, et al
    Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.
    J Viral Hepat. 2013;20:e115-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. BOGLIONE L , D'Avolio A, Cariti G, Milia MG, et al
    Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes.
    J Viral Hepat. 2013;20:e11-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. PILUSO A , Giannini C, Fognani E, Gragnani L, et al
    Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study.
    J Viral Hepat. 2013;20:e107-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. BREBAN R , Doss W, Esmat G, Elsayed M, et al
    Towards realistic estimates of HCV incidence in Egypt.
    J Viral Hepat. 2013;20:294-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. FIRDAUS R , Saha K, Sadhukhan PC
    Rapid immunoassay alone is insufficient for the detection of hepatitis C virus infection among high-risk population.
    J Viral Hepat. 2013;20:290-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. SHINDO H , Maekawa S, Komase K, Miura M, et al
    IL-28B (IFN-lambda3) and IFN-alpha synergistically inhibit HCV replication.
    J Viral Hepat. 2013;20:281-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. ZHENG YY , Wang LF, Fan XH, Wu CH, et al
    Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C.
    J Viral Hepat. 2013;20:273-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. ANGULO J , Pino K, Pavez C, Biel F, et al
    Genetic variations in host IL28B links to the detection of peripheral blood mononuclear cells-associated hepatitis C virus RNA in chronically infected patients.
    J Viral Hepat. 2013;20:263-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. KATSOULIDOU A , Manesis E, Rokka C, Issaris C, et al
    Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D.
    J Viral Hepat. 2013;20:256-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. ZHENG MH , Shi KQ, Lin XF, Xiao DD, et al
    A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network.
    J Viral Hepat. 2013;20:248-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. FRIEDRICH-RUST M , Buggisch P, de Knegt RJ, Dries V, et al
    Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B.
    J Viral Hepat. 2013;20:240-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. PEVELING-OBERHAG J , Herrmann E, Kronenberger B, Farnik H, et al
    Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs.
    J Viral Hepat. 2013;20:234-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. FOURNIER C , Duverlie G, Castelain S
    Are trans-complementation systems suitable for hepatitis C virus life cycle studies?
    J Viral Hepat. 2013;20:225-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Virol

52. LI C , Wang Y, Wang S, Wu B, et al
    Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion.
    J Virol. 2013;87:2193-205.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Lancet

53. KOWDLEY KV , Lawitz E, Crespo I, Hassanein T, et al
    Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial.
    Lancet. 2013 Mar 14. pii: S0140-6736(13)60247.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. DUSHEIKO G , Burney T
    Hepatitis C treatment: interferon free or interferon freer?
    Lancet. 2013 Mar 14. pii: S0140-6736(13)60636.
    PubMed     Text format     Related articles   
    
    
    

    
    PLoS Comput Biol

55. RONG L , Guedj J, Dahari H, Coffield DJ Jr, et al
    Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model.
    PLoS Comput Biol. 2013;9:e1002959.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    PLoS One

56. SHAO X , Qian Y, Xu C, Hong B, et al
    The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-Induced Hepatitis in Mice.
    PLoS One. 2013;8:e58836.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. DU NN , Peng ZG, Bi CW, Tang S, et al
    N-Substituted Benzyl Matrinic Acid Derivatives Inhibit Hepatitis C Virus (HCV) Replication through Down-Regulating Host Heat-Stress Cognate 70 (Hsc70) Expression.
    PLoS One. 2013;8:e58675.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. HAN Y , Pu R, Han X, Zhao J, et al
    Associations of pri-miR-34b/c and pre-miR-196a2 Polymorphisms and Their Multiplicative Interactions with Hepatitis B Virus Mutations with Hepatocellular Carcinoma Risk.
    PLoS One. 2013;8:e58564.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. UEDA Y , Kaido T, Ogura Y, Ogawa K, et al
    Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.
    PLoS One. 2013;8:e58380.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. LAMAS LONGARELA O , Schmidt TT, Schoneweis K, Romeo R, et al
    Proteoglycans act as cellular hepatitis delta virus attachment receptors.
    PLoS One. 2013;8:e58340.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. KITA Y , Takamura T, Misu H, Ota T, et al
    Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis.
    PLoS One. 2012;7:e43056.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Proc Natl Acad Sci U S A

62. CHANDRIANI S , Skewes-Cox P, Zhong W, Ganem DE, et al
    Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis.
    Proc Natl Acad Sci U S A. 2013.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Transplant Proc

63. YASAR DG , Suyani E, Ozenirler S, Sucak GT, et al
    Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
    Transplant Proc. 2013;45:833-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. ZHAO XY , Rakhda MI, Wang TI, Jia JD, et al
    Immunoglobulin g4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
    Transplant Proc. 2013;45:824-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. TE HS , Drobeniuc J, Kamili S, Dong C, et al
    Hepatitis e virus infection in a liver transplant recipient in the United States: a case report.
    Transplant Proc. 2013;45:810-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Transplantation

66. IKEGAMI T , Shirabe K, Yoshizumi T, Furusyo N, et al
    Impact of Conversion From Pegylated Interferon-alpha2b to Interferon-alpha2a for Treating Recurrent Hepatitis C After Liver Transplantation.
    Transplantation. 2013;95:e38-42.
    PubMed     Text format     Related articles   
    
    
    

    
    Vaccine

67. WANG JM , Ma CJ, Li GY, Wu XY, et al
    Tim-3 alters the balance of IL-12/IL-23 and drives T17 cells: Role in hepatitis B vaccine failure during hepatitis C infection.
    Vaccine. 2013 Mar 13. pii: S0264-410X(13)00262.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Virology

68. ANSARI IU , Allen T, Berical A, Stock PG, et al
    Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility.
    Virology. 2013;436:268-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through a media sponsorship by Boehringer Ingelheim.

All AMEDEO services are free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Amedeo is a Flying Publisher website.    Design: